See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rebif
What is Interferon beta-1a SubQ injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
See more information, including instructions, precautions, side effects, and interactions.
1663 patients in the community are taking or have taken Interferon beta-1a SubQ injection.
Top 10 (Show all)
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 1249 | 75% |
| Multiple Sclerosis (MS) | 68 | 4% |
| Other | 46 | 2% |
| Stiffness/Spasticity | 16 | <1% |
| General health | 14 | <1% |
| Fatigue | 13 | <1% |
| disease-related symptoms | 10 | <1% |
| Don't know | 5 | <1% |
| Mobility | 5 | <1% |
| Support another treatment | 2 | <1% |
Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a IM Injection, and Interferon beta-1b SubQ Injection.
Based on the patients currently taking Interferon beta-1a SubQ injection.
Top 10 (Show all)
All (Show top 10)
| 0.44 mg as needed | 132mcg weekly | 22 mcg/0.5 mL as needed | 22mcg/0.5mL as needed | 3 44mcg/0.5mL as needed | 3 times a week | 44 mcg/0.5 mL all the time (24/7) | 44 mcg/0.5 mL as needed | 44mcg/0.5mL as needed | 44 mcg all the time (24/7) | 44mcg as needed | 44 mg all the time (24/7) | 44mg as needed | - as needed | as needed | daily | monthly | weekly | 0.14 mcg | 0.44 mg weekly | 0.5 mcg weekly | 0.5 mg weekly | 0.22 mg | 0.25 mcg | 0.25 mg | 1 g weekly | 1 weekly | 0.3 mcg | 0.3 mg | 1.1 weekly | 0.44 mcg | 0.5 mcg | 0.44 | 0.44 mcg | 0.44 mg | 0.5 mcg | 0.3 mcg daily | 0.3 mg daily | 0.8 mcg | 0.75 mg | 1 mcg | 3 mcg weekly | 3 mg weekly | 3 weekly | 1 | 1 mcg | 1 mg | 4.4 mcg weekly | 30 mcg/0.5 mL monthly | 1 mL daily | 8.8 mcg weekly | 3 mcg | 3 mcg | 3 mg | 4.4 mcg | 15 mcg weekly | 20 mg weekly | 3 mg daily | 22 mcg/0.5 mL weekly | 22 mcg weekly | 22 mg weekly | 26.4 mcg weekly | 10 mcg | 30 mcg/0.5 mL weekly | 30 mcg weekly | 30 mg weekly | 8.8 mg | 33 mg weekly | 10 | 12 mcg | 40 mcg weekly | 40.5 mcg weekly | 44 mcg/0.5 mL weekly | 44 mcg weekly | 44 mg weekly | 44 weekly | 60 mg weekly | 8.8 mcg daily | 8.8 mg daily | 22 mcg | 22 mcg/0.5 mL | 22 mcg/0.5 mL 3 times a week | 3 x 22 mcg/0.5 mL weekly | 66 mcg weekly | 66 mg weekly | 10 mg daily | 22 | 22 mcg | 22 mg | 25 mg | 2 x 44 mcg/0.5 mL weekly | 88 mcg weekly | 30 mcg/0.5 mL 3 times a week | 33 mcg | 99 mcg weekly | 30 mcg | 112 mcg weekly | 40 mcg | 120 mg weekly | 12 x 44 mcg/0.5 mL monthly | 126 mcg weekly | 44 mcg | 44 mcg/0.5 mL 3 times a week | 132 mcg weekly | 132 mg weekly | 3 x 44 mcg/0.5 mL weekly | 40 | 41 mcg | 43 mg | 152 mg weekly | 22 mcg/0.5 mL daily | 22 mcg daily | 44 | 44 g | 44 mcg | 44 mg | 4 x 44 mcg/0.5 mL weekly | 30 mcg/0.5 mL daily | 30 mcg daily | 6 x 44 mcg/0.5 mL weekly | 100 mcg | 300 weekly | 44 mcg/0.5 mL daily | 44 mcg/0.5 mL one time | 44 mcg daily | 132 mcg | 138 mcg | 125 | 132 mcg | 144 mg | 100 mcg daily | 200 mcg | 200 mg | 132 mcg daily | 3 x 44 mcg/0.5 mL daily | 321 mcg | 300 mg | 200 g daily | 250 mcg daily | 500 mcg | 300 other daily | 44 mcg | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
3
|
1
|
25
|
1
|
4
|
11
|
1
|
3
|
1
|
1
|
1
|
4
|
16
|
1
|
24
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
8
|
1
|
2
|
1
|
2
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
2
|
3
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
7
|
3
|
3
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
63
|
35
|
16
|
1
|
1
|
1
|
1
|
8
|
1
|
16
|
31
|
4
|
2
|
1
|
2
|
2
|
5
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
87
|
48
|
34
|
17
|
184
|
1
|
1
|
1
|
1
|
13
|
2
|
19
|
1
|
36
|
77
|
1
|
2
|
6
|
1
|
1
|
1
|
87
|
1
|
17
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 275 | 50% | |
| Did not seem to work | 185 | 34% | |
| Doctor's advice | 130 | 24% | |
| Other | 89 | 16% | |
| Personal research | 27 | 5% | |
| Expense | 21 | 4% | |
| Not indicated | 15 | 3% | |
| Course of treatment ended | 9 | 2% |
Results from 259 patient evaluations. See the overall results and all individual evaluations.
| Major | 16% | 34 |
|---|---|---|
| Moderate | 14% | 31 |
| Slight | 13% | 29 |
| None | 11% | 24 |
| Can't tell | 45% | 98 |
Slow my MS progress
| Severe | 15% | 39 |
|---|---|---|
| Moderate | 36% | 94 |
| Mild | 38% | 99 |
| None | 10% | 27 |
Top reported side-effects include: Injection site redness, Muscle ache, whole body, Chills/fever
Summary results are based on 259 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta-1a SubQ injection
Report created on November 07, 2009.